Clinical Blog
Published: February 28, 2022

Reducing dose frequency may help improve asthma medication adherence

Findings from a Propeller Health study recently published in The Journal of Allergy and Clinical Immunology demonstrated that patients with asthma who are prescribed once-daily dosing schedules are more likely to adhere to their controller medications than those with twice-daily prescriptions.

Medication adherence data was collected from 6,410 patients who used the Propeller digital health platform. The platform’s inhaler sensors attach to a patient’s inhaler medications and passively capture the date and time of controller medication use. 

Following a three-month study period, we found that on average, once-daily users had significantly higher daily adherence than twice-daily users. This pattern persisted even when comparing adherence rates across age groups, with the exception of 4-11 year olds, who may benefit from additional parental oversight.

The percentage of patients who achieved greater than 80% adherence was also significantly higher for once-daily users compared to twice-daily users, with once-daily users being 1.4 times as likely to achieve high medication adherence as twice-daily users. 

Bar graph showing treatment adherence in patients with asthma by age group

What might this mean for patients and clinicians who use digital health tools to manage or monitor asthma? While not all patients with asthma may benefit from a simplified dosing schedule, this study highlights the value in utilizing objective medication adherence data to evaluate dose frequency and treatment plans together. Without objective data, clinicians typically have to rely on patient recall or manual tracking before deciding how best to adjust regimens. 

This research contributes to a growing body of evidence that digital health platforms can be effective tools for tracking patient medication adherence and providing clear insights for clinicians to make informed care decisions, particularly around medication optimization – a critical component of asthma management. 

To learn more about how Propeller’s objective insights can help you make more informed care decisions, please contact

You Might Also Like

Pharma’s Biggest Takeaways From the 2023 J.P. Morgan Healthcare Conference

At J.P. Morgan’s 41st annual healthcare conference, there was no shortage of innovative discussions. We’ve rounded up some of the biggest themes from this year’s conference:

Connected drug delivery devices are gaining traction among top pharma companies

As medication non-adherence continues to plague the global life sciences industry – more than $600 billion in annual revenue is lost1 – many pharmaceutical companies are evaluating new approaches to improving patient engagement, including embedded sensors that capture data through drug delivery devices. One of the biggest selling points for organizations is that connected drug delivery devices can play a huge role in boosting adherence and compliance. Devices that can detect and capture data around patient-administered therapy, such as dose timing, volume, and technique, have become an increasingly popular choice among leading organizations. Patients are more likely to refill and take their medications on time, and correctly, if they can be prompted to do so and have a record of dosing history. 

In Value We Trust: How Health Systems Can Drive Population Health With Digital Solutions

With perpetually rising healthcare costs, soaring operating expenses, and plummeting profit margins, health systems are pressured to re-evaluate their care delivery models and shift their focus to value.

Implementing the right tools to enhance decision making and build care management capabilities for population health, risk stratification, and site-of-care optimization will be vital for navigating this actively evolving landscape. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings. 

In an outcomes-based payment model, health systems can leverage digital solutions to:

Raising the Volume: How Health Systems Can Overcome Economic Turmoil With Digital Solutions

A staggering 97% of medical practices experienced a negative financial impact at the beginning of the pandemic, including a 60% decrease in patient volume and a 55% decline in revenue.1 Nearly three years later, more than half of hospitals are still experiencing negative margins.2 

To ensure success in this actively evolving landscape, health systems must equip themselves with the right tools to enhance decision making and reduce administrative burden through frictionless clinician experiences. Digital health solutions are critical enablers of success, especially having demonstrated clinical and real-world outcomes in all reimbursement settings. 

In a traditional payment model, digital solutions can help health systems: